---
figid: PMC6651569__molecules-24-02383-g001
figtitle: Signaling pathways selected for the evaluation of the biological effects
  of essential oils
organisms:
- Armoracia rusticana
- Curcuma longa
- Cinnamomum verum
- Ocimum basilicum
- Angelica sinensis
- Origanum vulgare
- Melissa officinalis
- Citrus nobilis
- Copaifera langsdorffii
- Copaifera multijuga
- Homo sapiens
- Mus musculus
- Bos taurus
organisms_ner:
- Mus musculus
- Homo sapiens
- Bos taurus
- Drosophila melanogaster
pmcid: PMC6651569
filename: molecules-24-02383-g001.jpg
figlink: /pmc/articles/PMC6651569/figure/molecules-24-02383-f001/
number: F1
caption: Signaling pathways selected for the evaluation of the biological effects
  of essential oils. (a) The mitogen-activated protein kinase (MAPK) signaling pathway
  that regulates cell growth and differentiation. EGF—epidermal growth factor; EGFR—epidermal
  growth factor receptor; FGF—fibroblast growth factor; FGFR—fibroblast growth factor
  receptor; SOS—guanine nucleotide exchange factors; RAS—small GTPases; serine/threonine-specific
  protein kinases; MEK1/2—mitogen-activated protein kinase kinase; ERK1/—extracellular
  signal-regulated kinase 1/2. (b) The pI3K/Akt/mTOR signaling pathway that regulates
  cell metabolism. IR—insulin receptor; pI3K—phosphoinositide 3-kinase; Akt—protein
  kinase B; mTOR—mammalian target of rapamycin; 4EBP1—eukaryotic translation initiation
  factor 4E-binding protein 1. (c) The JAK/STAT signaling pathway that regulates the
  cellular immune response. JAK—Janus kinase; STAT—signal transducer and activator
  of transcription protein. P—phosphate group; solid arrows—direct regulation; dashed
  arrows—indirect regulation via one or more intermediates. The right to use the DNA
  double helix illustration was purchased with the standard image license (honglouwawa/shutterstock.com).
papertitle: Differentiation of Essential Oils Using Nanofluidic Protein Post-Translational
  Modification Profiling.
reftext: Yasuyo Urasaki, et al. Molecules. 2019 Jul;24(13):2383.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9009181
figid_alias: PMC6651569__F1
figtype: Figure
redirect_from: /figures/PMC6651569__F1
ndex: 57186320-df13-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6651569__molecules-24-02383-g001.html
  '@type': Dataset
  description: Signaling pathways selected for the evaluation of the biological effects
    of essential oils. (a) The mitogen-activated protein kinase (MAPK) signaling pathway
    that regulates cell growth and differentiation. EGF—epidermal growth factor; EGFR—epidermal
    growth factor receptor; FGF—fibroblast growth factor; FGFR—fibroblast growth factor
    receptor; SOS—guanine nucleotide exchange factors; RAS—small GTPases; serine/threonine-specific
    protein kinases; MEK1/2—mitogen-activated protein kinase kinase; ERK1/—extracellular
    signal-regulated kinase 1/2. (b) The pI3K/Akt/mTOR signaling pathway that regulates
    cell metabolism. IR—insulin receptor; pI3K—phosphoinositide 3-kinase; Akt—protein
    kinase B; mTOR—mammalian target of rapamycin; 4EBP1—eukaryotic translation initiation
    factor 4E-binding protein 1. (c) The JAK/STAT signaling pathway that regulates
    the cellular immune response. JAK—Janus kinase; STAT—signal transducer and activator
    of transcription protein. P—phosphate group; solid arrows—direct regulation; dashed
    arrows—indirect regulation via one or more intermediates. The right to use the
    DNA double helix illustration was purchased with the standard image license (honglouwawa/shutterstock.com).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Akt1
  - Pik3r1
  - Mtor
  - Egf
  - Egfr
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Mdk
  - Ephb2
  - Mapk1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MTOR
  - EGF
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EREG
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - EGFR
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MKP-4
  - p38b
  - rl
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Tor
  - bnl
  - ine
  - btl
  - htl
  - Sos
  - Ras64B
  - Ras85D
  - Stat92E
  - Raf
  - Dsor1
  - Mtk
  - Erk7
  - Is
  - bos
  - boss
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
